Notícias

Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.

30,459 signal articles · 149 in last 24h · 154,156 total before filter · latest 1h ago

149last 24h

876last 7d

146● bullish (7d)

96● bearish (7d)

214publishers

All Macro212 Earnings108 M&A125 Regulatory21 Product21 Analyst17

✕ clear all filtersticker: GILDsentiment: bullishSentiment:bullish neutral bearish show all (incl. clickbait)

Insider Monkey89d agobullish

Gilead (GILD) Wins FDA Approval for Trodelvy in TNBC

Gilead Sciences, Inc. (NASDAQ:GILD) is one of the 12 Most Profitable S&P 500 Stocks to Invest In. On June 25, 2026, the Food and Drug Administration approved Trodelvy from Gilead Sciences, Inc. (NASDAQ:GILD) for two indications in adults with triple-negative breast cancer. The first approval covers sacituzumab govitecan-hziy as a single agent for the first-line […]

GILD MRK ^GSPC

Stocktwits125d agobullish

GILD Stock Jumps After Winning Accelerated FDA Approval For HDV Treatment

U.S. Food and Drug Administration (FDA) approved Hepcludex (bulevirtide-gmod) injection to treat chronic hepatitis delta virus.

GILD